Bioelectric stimulator
Described is a low voltage, pulsed electrical stimulation device for controlling expression of, for example, follistatin, a muscle formation promotion protein, by tissues. Epicardial stimulation is especially useful for heart treatment. Follistatin controlled release is also useful for treating other ailments, such as erectile dysfunction, aortic aneurysm, and failing heart valves.
1. A bioelectric stimulator programmed to produce a bioelectric signal or bioelectric signals that stimulate(s) target tissue in a subject, wherein the bioelectric signal(s) comprise(s) bioelectric signal(s) selected from the group consisting of
(a) within 15%, 6 mV at 150 Hz, monophasic square wave pulse, 0.1 ms in duration, at a current of fifteen (15) mA,
(b) within 15%, 10 V/cm, pulse-width 180 μs, 500 Hz,
(c) 3 V/cm, 10 Hz, 2 μA, with a pulse duration of 0.2 ms,
(d) within 15%, 3 mV with a frequency of about 22 Hz, and a current of about 1 mA, followed by 3 mA,
(e) 3 mV at 2/100 Hz, alternating frequency, with current of 3 mA, followed by 15 Hz, 1 Gauss EM field, consisting of 5-mlllisecond bursts with 5-microsecond pulses followed by 200 μs pulse duration at 30 Hz and with current amplitude of 140 mA,
(f) within 15%, alternating high-frequency (HF) and medium-frequency signals (MF), symmetric, biphasic, trapezoid pulses, with 400-μs pulse duration and 1.5/1-s ramp-up/ramp-down duration, respectively, and
(g) any combination(s) thereof.
2. The bioelectric stimulator of claim 1 , wherein the bioelectric stimulator is further programmed to produce and produces a bioelectric signal that upregulates expression of stromal cell-derived factor 1 (“SDF-1”) in the target tissue.
3. A method of using the bioelectric stimulator of claim 2 , in a subject's target tissue to upregulate expression of a protein,
wherein the bioelectric signal upregulates expression by the subject's target tissue of a protein selected from the group consisting of insulin-like growth factor 1 (“IGF-1”), epidermal growth factor (“EGF”), platelet-derived growth factor (“PDGF”), endothelial NOS (“eNOS”), activin B, receptor activator of nuclear factor kappa-B ligand (“RANKL”), and any combination thereof.
4. The method according to claim 3 , wherein the target tissue comprises blood vessels of the subject, and the method comprises:
generating a bioelectric signal or bioelectric signals from the bioelectric stimulator to upregulate expression of selected protein(s) by the target tissue,
wherein the selected protein(s) comprise(s) protein(s) selected from the group consisting of IGF-1, EGF, HGF, PDGF, eNOS, and any combination thereof.
5. The method according to claim 3 , wherein the target tissue comprises brain cells and the method comprises:
generating bioelectric signals from the bioelectric stimulator to modulate the expression of selected protein(s) by the target tissue, wherein the protein(s) comprise(s) protein(s) selected from the group consisting of IGF-1, activin B, eNOS, PDGF, and any combination thereof.
6. The method according to claim 5 , further comprising:
separately delivering to the subject stem cells and/or growth factors comprising any combination comprising of GDF-10, GDF-11, SDF-1, IGF-1, HGH, activin A, activin B, eNOS, HIF-1α, IL-6, PDGF, HGF, and tropoelastin.
7. The method according to claim 3 , wherein the target tissue comprises muscle tissue, the method comprising:
generating bioelectric signals from the bioelectric stimulator to upregulate the expression of selected protein(s) by the muscle tissue, wherein the protein(s) comprise(s) protein(s) selected from the group consisting of SDF-1, IGF-1, HGF, EGF, PDGF, and any combination thereof.
8. A method of using the bioelectric stimulator of claim 1 , wherein the target tissue is an organ of the subject, the method comprising:
delivering selected bioelectric signals to the organ so as to upregulate expression of selected protein(s) in the organ.
9. The method according to claim 8 , further comprising:
separately delivering to the subject an admixture comprising any combination of the following: stem cells, endothelial progenitor cells, selected exosomes, selected alkaloids, selected anti-inflammatory agents, nutrient hydrogel, organ specific matrix, selected growth factors, amniotic fluid, placenta fluid, cord blood, and embryonic sourced growth factors and cells.
10. A method of using the bioelectric stimulator of claim 1 in a subject to repair DNA, the method comprising:
generating bioelectric signals from the bioelectric stimulator to increase the expression of a protein by target tissue of the subject,
wherein the bioelectric signal is, within 15%, 3 mV with a frequency of about 22 Hz, and a current of about 1 mA for about fifteen (15) minutes and 3 mA for about fifteen (15) minutes as measured three (3) mm deep into the target tissue.
11. A method of using the bioelectric stimulator of claim 1 , wherein the target tissue is selected from the group consisting of brain, scalp, eye, ear, skin, tooth, dental gum, tooth root, sub-mucosa, breast, aorta, limb, artery, heart, heart valve, kidney, pancreas, bladder, liver, joint, bone, and any combination thereof.
12. A method of using the bioelectric stimulator of claim 1 , to achieve a desired result, wherein the desired result is selected from the group consisting of improving quantity and quality of fish in aquaculture systems, improving milk production in a mammal, renewing strength and vitality in living animals, muscle regeneration, improving urine output, and any combination thereof.
13. The bioelectric stimulator of claim 1 , wherein the bioelectric signal is, within 15%, 6 mV at 150 Hz, monophasic square wave pulse, 0.1 ms in duration, at a current of fifteen (15) mA.
14. The bioelectric stimulator of claim 1 , wherein the bioelectric signal is, within 15%, 10 V/cm, pulse-width 180 μs, 500 Hz.
15. The bioelectric stimulator of claim 1 , wherein the bioelectric signal is 3 V/cm, 10 Hz, 2 μA, with a pulse duration of 0.2 ms.
16. The bioelectric stimulator of claim 1 , wherein the bioelectric signal is, within 15%, 3 mV with a frequency of about 22 Hz, and a current of about 1 mA, followed by 3 mA.
17. The bioelectric stimulator of claim 1 , wherein the bioelectric signal is 3 mV at 2/100 Hz, alternating frequency, with current of 3 mA, followed by 15 Hz, 1 Gauss EM field, consisting of 5-mlllisecond bursts with 5-microsecond pulses followed by 200 μs pulse duration at 30 Hz and with current amplitude of 140 mA.
18. The bioelectric stimulator of claim 1 , wherein the bioelectric signal is, within 15%, alternating high-frequency (HF) and medium-frequency signals (MF), symmetric, biphasic, trapezoid pulses, with 400-μs pulse duration and 1.5/1-s ramp-up/ramp-down duration, respectively.
19. A bioelectric stimulator programmed to produce bioelectric signals that stimulate a subject to stimulate stem cell homing to a target tissue, stem cell proliferation, and stem cell differentiation,
wherein the bioelectric signal to stimulate stem cell homing comprises 30 Hz with a voltage of 3.5 mV, and successively alternating currents of 700 to 1500 picoamps for one minute, and again with 700 to 1500 picoamps for one minute, plus stimulated with a current of 0.25 mA, pulse duration of 40 pulses per second, pulse width of 100 μs, and frequency of 100 Hz,
wherein the bioelectric signal to stimulate stem cell proliferation is 15 mV and a current of 500 picoamps at 70 pulses per minute for 3 hours and 20 pulses per minute, a pulse amplitude of from 2.5 to 6 volts, and a pulse width of from 0.2 to 0.7 milliseconds or wherein the bioelectric signal to stimulate stem cell proliferation is from 2.5 to 6.0 V, 20 Hz, pulse width 200 to 700 μs, square wave, and
wherein the bioelectric signal to stimulate stem cell differentiation is 200 picoamps for 10 seconds with a pulse having an amplitude of 5 V and a width of 0.5 milliseconds or wherein the bioelectric signal to stimulate stem cell differentiation is to reverse polarity and reduce the voltage of the bioelectric signal to stimulate stem cell proliferation.
20. The bioelectric stimulator of claim 19 , wherein the bioelectric stimulator is further programmed to produce a bioelectric signal to modulate the expression of protein(s).
21. A method of using the bioelectric stimulator of claim 19 , the method comprising:
administering the bioelectric signals to the subject with the bioelectric stimulator so as to stimulate stem cell homing, stem cell proliferation, and stem cell differentiation in the target tissue,
wherein each of the bioelectric signals to stimulate stem cell homing is administered for from 40 minutes to 8 hours,
wherein the bioelectric signal to stimulate stem cell proliferation is administered for 3 hours, and
wherein the bioelectric signal to stimulate stem cell differentiation is administered for one hour.